NuvoAir, the digital respiratory health care platform that helps manage asthma and chronic obstructive pulmonary disease (COPD), announced that it has secured $11 million in funding from UK-based Hikma Ventures to expand its patient-centric care and clinical trials platform. The company said that the money will be used to speed up its clinical services launch with risk-bearing providers and health plans. NuvoAir founder and CEO Lorenzo Consoli said that the company will focus more on treating complex COPD and asthmatic patients. Stressing on their patient-centric approach, Consoli also expressed hopes that their platform will benefit many.